Optomed
3.8
EUR
-3.06 %
5,448 following
OPTOMED
NASDAQ Helsinki
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
-3.06%
-11.21%
-18.45%
-20.25%
-23%
-5.59%
-31.16%
-14.99%
-17.03%
Optomed is a medical technology company. The company conducts research and development of specialized eye cameras. Development takes place of both hardware and software that is resold under different brands. The company operates worldwide, with the largest presence in the Nordic market. The customers consist of research institutes and hospitals. Optomed is headquartered in Oulu.
Read moreMarket cap
74.83M EUR
Turnover
222.19K EUR
P/E (adj.) (25e)
-14.76
EV/EBIT (adj.) (25e)
-15.58
P/B (25e)
3.92
EV/S (25e)
4.22
Dividend yield-% (25e)
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
6.5
2025
Interim report Q1'25
7.8
2025
Interim report Q2'25
6.11
2025
Interim report Q3'25
Risk
Business risk
Valuation risk
Low
High
ShowingAll content types
Redeye: Optomed Q4 - Quarter in line with expectations
Optomed Oyj: Optomed Plc: Financial Statements Bulletin, January - December 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Optomed Oyj: Proposal of Optomed's Nomination Board
